Although the action of irinotecan on CRC cells was demonstrated to be impaired by the activation of STAT3 [47], it is not known whether the nuclear translocation of pSTAT3 in CRC cells is directly involved in the decrease in TOPO1 expression in CRC cells. This evidence concerns the gene STAT3 and colorectal carcinoma.